Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib
Public ClinicalTrials.gov record NCT00101660. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study to Determine the Activity of BMS-354825 in Subjects With Chronic Phase Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Disease That is Resistant to High Dose Imatinib Mesylate (Gleevec) or Who Are Intolerant of Imatinib
Study identification
- NCT ID
- NCT00101660
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 387 participants
Conditions and interventions
Interventions
- Dasatinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2005
- Primary completion
- Aug 31, 2006
- Completion
- Mar 31, 2008
- Last update posted
- Mar 1, 2012
2005 – 2008
United States locations
- U.S. sites
- 32
- U.S. states
- 21
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Anaheim | California | — | — |
| Local Institution | Loma Linda | California | — | — |
| Local Institution | Los Angeles | California | — | — |
| Local Institution | Stanford | California | — | — |
| Local Institution | Vallejo | California | — | — |
| Local Institution | Hartford | Connecticut | — | — |
| Local Institution | Washington D.C. | District of Columbia | — | — |
| Local Institution | Jacksonville | Florida | — | — |
| Local Institution | Tampa | Florida | — | — |
| Local Institution | Atlanta | Georgia | — | — |
| Local Institution | Chicago | Illinois | — | — |
| Local Institution | Indianapolis | Indiana | — | — |
| Local Institution | Kansas City | Kansas | — | — |
| Local Institution | Baltimore | Maryland | — | — |
| Local Institution | Boston | Massachusetts | — | — |
| Local Institution | Detroit | Michigan | — | — |
| Local Institution | Kansas City | Missouri | — | — |
| Local Institution | St Louis | Missouri | — | — |
| Local Institution | Omaha | Nebraska | — | — |
| Local Institution | Hackensack | New Jersey | — | — |
| Local Institution | New Brunswick | New Jersey | — | — |
| Local Institution | New York | New York | — | — |
| Local Institution | Portland | Oregon | — | — |
| Local Institution | Philadelphia | Pennsylvania | — | — |
| Local Institution | Pittsburgh | Pennsylvania | — | — |
| Local Institution | Greenville | South Carolina | — | — |
| Local Institution | Nashville | Tennessee | — | — |
| Local Institution | Dallas | Texas | — | — |
| Local Institution | Houston | Texas | — | — |
| Local Institution | San Antonio | Texas | — | — |
| Local Institution | Tyler | Texas | — | — |
| Local Institution | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00101660, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 1, 2012 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00101660 live on ClinicalTrials.gov.